XPH

Featured

ETFs for Hedge Funds’ Favorite Pharma Stocks

By Tom LydonAugust 25, 2014

Featured

Some ETFs Salivating for a Salix Takeover

By Tom LydonAugust 20, 2014

Featured

Bill Ackman Might Like These Pharma ETFs

By Tom LydonApril 22, 2014

Featured

Deal for Forest Fantastic for Pharma ETFs

By Tom LydonFebruary 18, 2014

Featured

Health Care Still Delivering as Other Sectors Struggles

By Tom LydonJanuary 31, 2014

Featured

Fun With Pharma ETFs

By Tom LydonJanuary 21, 2014

Featured

ETF ‘In-Kind’ Redemptions Help Limit Capital Gains

By Max ChenDecember 18, 2013

Featured

ETF Performance Report: November

By Tom LydonNovember 29, 2013

Featured

Pharma ETFs Could Flatline on Obamacare Bust

By Max ChenNovember 20, 2013

Featured

Help From the Hill Could Add to Pharma ETFs’ Gains

By Tom LydonNovember 16, 2013

Featured

Sturdy Pharma ETF Could Pullback

By Tom LydonOctober 22, 2013

Featured

Large-Cap Equity ETFs Outperforming in 2013

By Tom LydonJuly 3, 2013

Featured

Election Could Make or Break Health Care ETFs

By Tom LydonSeptember 18, 2012

Featured

Pharmaceutical ETFs: A Defensive Play in 2012?

By Tom LydonApril 25, 2012

Featured

ETF Spotlight: Pharmaceuticals

By Tom LydonOctober 13, 2011

Featured

Pharma, Healthcare ETFs in Focus on M&A Talk, Earnings

By John SpenceApril 18, 2011

Featured

Pharmaceutical ETFs Look to the Future

By Tom LydonJanuary 29, 2011

Featured

Pharmaceutical ETFs: Drug Companies Roar Back

By Tom LydonNovember 16, 2010

Previous 1 2 3 4 Next